ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
9.13
-0.60 (-6.17%)
At close: Jun 5, 2026, 4:00 PM EDT
9.48
+0.35 (3.83%)
After-hours: Jun 5, 2026, 5:06 PM EDT
ProMIS Neurosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
81.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ImmuCell | 29.93M |
| Pelthos Therapeutics | 27.70M |
| Atara Biotherapeutics | 23.14M |
| NeurAxis | 4.28M |
| Rani Therapeutics Holdings | 3.17M |
| Rallybio | 858.00K |
PMN News
- 2 days ago - ProMIS Neurosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 9 days ago - ProMIS Neurosciences to Participate in Upcoming Conferences in June - GlobeNewsWire
- 17 days ago - ProMIS Neurosciences Transcript: AGM 2026 - Transcripts
- 17 days ago - ProMIS Neurosciences initiated with a Buy at Brookline - TheFly
- 25 days ago - ProMIS Neurosciences reports Q1 EPS ($1.26) vs. ($5.27) last year - TheFly
- 25 days ago - ProMIS Neurosciences Earnings release: Q1 2026 - Filings
- 25 days ago - ProMIS Neurosciences Quarterly report: Q1 2026 - Filings
- 25 days ago - ProMIS Neurosciences Announces First Quarter 2026 Financial Results and Provides Corporate Highlights - GlobeNewsWire